Modulating hepatic macrophages with annexin A1 in non-alcoholic steatohepatitis

Non-alcoholic steatohepatitis (NASH) and associated end-stage liver disease is a growing cause of concern throughout the Western world. It constitutes a significant clinical burden for which therapeutic approaches are very limited. Over the last years, considerable attention has therefore been paid...

Descripción completa

Detalles Bibliográficos
Autores principales: De Ponti, Federico F., Scott, Charlotte L.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Portland Press Ltd. 2022
Materias:
Immunology & Inflammation
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9366860/
https://www.ncbi.nlm.nih.gov/pubmed/35913023
http://dx.doi.org/10.1042/CS20220258

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9366860/
https://www.ncbi.nlm.nih.gov/pubmed/35913023
http://dx.doi.org/10.1042/CS20220258

Ejemplares similares